
1 - 10 employees
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Braveheart Bio is a clinical-stage biotechnology company focused on transforming the care of hypertrophic cardiomyopathy (HCM) and related conditions. The company is developing investigational therapies that selectively target overactive myosin — a key disease mechanism in HCM — and is advancing a program through global late-stage (Phase 3) clinical development to improve heart performance and patient quality of life.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 October 6
Senior regulatory affairs manager advancing U.S. IND/NDA and global CTA/MAA submissions. Supporting Braveheart Bio’s cardiovascular drug development strategy and health authority interactions.
🕒 August 28
Senior quality compliance leader guiding GxP risk, audits, vendors, and inspections at Braveheart Bio. Supporting cardiovascular therapies through late-stage development and commercialization.